Bristol-Myers Squibb Company
RADIOLIGANDS FOR IMAGING THE IDO1 ENZYME
Last updated:
Abstract:
The present invention relates to radiolabeled IDO1 inhibitors or pharmaceutically acceptable salts thereof which are useful for the quantitative imaging of IDO enzymes in mammals.
Status:
Application
Type:
Utility
Filling date:
18 Jul 2017
Issue date:
19 Sep 2019